Ionis Pharmaceuticals Narrows Q1 Loss, Lifts Revenue Forecast While Drug Sales Surge
benzinga.com/general/biotech/25/04/45112123/ionis-pharmaceuticals-narrows-q1-loss-lifts-revenue-forecast-while-drug-sales-surge
Ionis Pharmaceuticals Inc (NASDAQ:IONS) reported a first-quarter EPS loss of 93 cents on Wednesday, down from a loss of 98 cents, beating the consensus of a $1.12 loss.
Revenue increased 10% in the first quarter of 2025 to $132 million, beating the consensus of $125.32 million, driven by…
This story appeared on benzinga.com, 2025-04-30 18:05:40.